common.study.topics.clinical

Testing Experimental Medication in Healthy Subjects

common.study.values.description

“Safety and Tolerability of PNT001 in Healthy Adults”

This first in human study is a multi-center, randomized, double-blind, placebo-controlled single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of intravenous PNT001 in healthy adult participants.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Biological - PNT001

PNT001 diluted in 5% dextrose

Drug - Placebo

5% dextrose

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-Ascending-Dose Trial to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of Intravenous PNT001 in Healthy Volunteers

common.study.values.clinical-trial-id

NCT04096287

participant.views.study.view.id

bo21ja